Global Systemic Psoriasis Therapeutics Market Insights, Forecast to 2029

Publisher Name :
Date: 14-Aug-2023
No. of pages: 90
Inquire Before Buying

Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.

Market Analysis and Insights: Global Systemic Psoriasis Therapeutics Market

The global Systemic Psoriasis Therapeutics market is projected to grow from US$ 12720 million in 2023 to US$ 19660 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.

One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.

Report Includes

This report presents an overview of global market for Systemic Psoriasis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Systemic Psoriasis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Systemic Psoriasis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Systemic Psoriasis Therapeutics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Systemic Psoriasis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Systemic Psoriasis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie, Johnson & Johnson, Celgene, Amgen and Pfizer, etc.

By Company

- AbbVie

- Johnson & Johnson

- Celgene

- Amgen

- Pfizer

Segment by Type

- Biologics

- Small Molecules

Segment by Application

- Mild Psoriasis

- Moderate Psoriasis

- Severe Psoriasis

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Systemic Psoriasis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Systemic Psoriasis Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Systemic Psoriasis Therapeutics revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Systemic Psoriasis Therapeutics Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biologics
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Mild Psoriasis
1.3.3 Moderate Psoriasis
1.3.4 Severe Psoriasis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Systemic Psoriasis Therapeutics Market Perspective (2018-2029)
2.2 Global Systemic Psoriasis Therapeutics Growth Trends by Region
2.2.1 Systemic Psoriasis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Systemic Psoriasis Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Systemic Psoriasis Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Systemic Psoriasis Therapeutics Market Dynamics
2.3.1 Systemic Psoriasis Therapeutics Industry Trends
2.3.2 Systemic Psoriasis Therapeutics Market Drivers
2.3.3 Systemic Psoriasis Therapeutics Market Challenges
2.3.4 Systemic Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Systemic Psoriasis Therapeutics by Players
3.1.1 Global Systemic Psoriasis Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Systemic Psoriasis Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Systemic Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Systemic Psoriasis Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Systemic Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Systemic Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Psoriasis Therapeutics Revenue in 2022
3.5 Global Key Players of Systemic Psoriasis Therapeutics Head office and Area Served
3.6 Global Key Players of Systemic Psoriasis Therapeutics, Product and Application
3.7 Global Key Players of Systemic Psoriasis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Systemic Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2024-2029)
5 Systemic Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Systemic Psoriasis Therapeutics Market Size (2018-2029)
6.2 North America Systemic Psoriasis Therapeutics Market Size by Type
6.2.1 North America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)
6.2.2 North America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
6.3 North America Systemic Psoriasis Therapeutics Market Size by Application
6.3.1 North America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)
6.3.2 North America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
6.4 North America Systemic Psoriasis Therapeutics Market Size by Country
6.4.1 North America Systemic Psoriasis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023)
6.4.3 North America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Systemic Psoriasis Therapeutics Market Size (2018-2029)
7.2 Europe Systemic Psoriasis Therapeutics Market Size by Type
7.2.1 Europe Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)
7.2.2 Europe Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
7.3 Europe Systemic Psoriasis Therapeutics Market Size by Application
7.3.1 Europe Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)
7.3.2 Europe Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
7.4 Europe Systemic Psoriasis Therapeutics Market Size by Country
7.4.1 Europe Systemic Psoriasis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Systemic Psoriasis Therapeutics Market Size by Country (2018-2023)
7.4.3 Europe Systemic Psoriasis Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Systemic Psoriasis Therapeutics Market Size (2018-2029)
8.2 China Systemic Psoriasis Therapeutics Market Size by Type
8.2.1 China Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)
8.2.2 China Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)
8.2.3 China Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
8.3 China Systemic Psoriasis Therapeutics Market Size by Application
8.3.1 China Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)
8.3.2 China Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)
8.3.3 China Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Systemic Psoriasis Therapeutics Market Size (2018-2029)
9.2 Asia Systemic Psoriasis Therapeutics Market Size by Type
9.2.1 Asia Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)
9.2.2 Asia Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
9.3 Asia Systemic Psoriasis Therapeutics Market Size by Application
9.3.1 Asia Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)
9.3.2 Asia Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
9.4 Asia Systemic Psoriasis Therapeutics Market Size by Region
9.4.1 Asia Systemic Psoriasis Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Systemic Psoriasis Therapeutics Market Size by Region (2018-2023)
9.4.3 Asia Systemic Psoriasis Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Systemic Psoriasis Therapeutics Introduction
11.1.4 AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)
11.1.5 AbbVie Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Systemic Psoriasis Therapeutics Introduction
11.3.4 Celgene Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)
11.3.5 Celgene Recent Developments
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Systemic Psoriasis Therapeutics Introduction
11.4.4 Amgen Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)
11.4.5 Amgen Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Systemic Psoriasis Therapeutics Introduction
11.5.4 Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2018-2023)
11.5.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Biologics
Table 3. Key Players of Small Molecules
Table 4. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Systemic Psoriasis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Systemic Psoriasis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Systemic Psoriasis Therapeutics Market Share by Region (2018-2023)
Table 8. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Systemic Psoriasis Therapeutics Market Share by Region (2024-2029)
Table 10. Systemic Psoriasis Therapeutics Market Trends
Table 11. Systemic Psoriasis Therapeutics Market Drivers
Table 12. Systemic Psoriasis Therapeutics Market Challenges
Table 13. Systemic Psoriasis Therapeutics Market Restraints
Table 14. Global Systemic Psoriasis Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Systemic Psoriasis Therapeutics Revenue Share by Players (2018-2023)
Table 16. Global Top Systemic Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Psoriasis Therapeutics as of 2022)
Table 17. Global Systemic Psoriasis Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Systemic Psoriasis Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Systemic Psoriasis Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Systemic Psoriasis Therapeutics, Product and Application
Table 21. Global Key Players of Systemic Psoriasis Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2024-2029)
Table 27. Global Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Systemic Psoriasis Therapeutics Revenue Share by Application (2018-2023)
Table 29. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Systemic Psoriasis Therapeutics Revenue Share by Application (2024-2029)
Table 31. North America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Systemic Psoriasis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Systemic Psoriasis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Systemic Psoriasis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Systemic Psoriasis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Systemic Psoriasis Therapeutics Product
Table 66. AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)
Table 67. AbbVie Recent Developments
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Systemic Psoriasis Therapeutics Product
Table 71. Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Developments
Table 73. Celgene Company Details
Table 74. Celgene Business Overview
Table 75. Celgene Systemic Psoriasis Therapeutics Product
Table 76. Celgene Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Celgene Recent Developments
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Systemic Psoriasis Therapeutics Product
Table 81. Amgen Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Amgen Recent Developments
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Systemic Psoriasis Therapeutics Product
Table 86. Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Pfizer Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Systemic Psoriasis Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Biologics Features
Figure 4. Small Molecules Features
Figure 5. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Systemic Psoriasis Therapeutics Market Share by Application: 2022 VS 2029
Figure 7. Mild Psoriasis Case Studies
Figure 8. Moderate Psoriasis Case Studies
Figure 9. Severe Psoriasis Case Studies
Figure 10. Systemic Psoriasis Therapeutics Report Years Considered
Figure 11. Global Systemic Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Systemic Psoriasis Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Systemic Psoriasis Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global Systemic Psoriasis Therapeutics Market Share by Players in 2022
Figure 15. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Psoriasis Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2022
Figure 17. North America Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
Figure 19. North America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
Figure 20. North America Systemic Psoriasis Therapeutics Market Share by Country (2018-2029)
Figure 21. United States Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
Figure 25. Europe Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
Figure 26. Europe Systemic Psoriasis Therapeutics Market Share by Country (2018-2029)
Figure 27. Germany Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
Figure 35. China Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
Figure 36. Asia Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
Figure 38. Asia Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
Figure 39. Asia Systemic Psoriasis Therapeutics Market Share by Region (2018-2029)
Figure 40. Japan Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Systemic Psoriasis Therapeutics Market Share by Country (2018-2029)
Figure 50. Brazil Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Systemic Psoriasis Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)
Figure 57. Johnson & Johnson Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)
Figure 58. Celgene Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)
Figure 59. Amgen Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Systemic Psoriasis Therapeutics Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
  • Global Glycated Albumin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Glycated Albumin market size was valued at US$ 419.7 million in 2023. With growing demand in downstream market, the Glycated Albumin is forecast to a readjusted size of US$ 593.8 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Glycated Albumin market. Glycated Albumin are expected to show stable growth in the future market. However, product differenti......
  • Global Neuropathy Pain Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Neuropathy Pain Treatment market size was valued at US$ 8341.5 million in 2023. With growing demand in downstream market, the Neuropathy Pain Treatment is forecast to a readjusted size of US$ 10560 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Neuropathy Pain Treatment market. Neuropathy Pain Treatment are expected to show stable growth in the futur......
  • Global Neuropathy Pain Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 92
    According to our (Global Info Research) latest study, the global Neuropathy Pain Treatment market size was valued at USD 8773.9 million in 2023 and is forecast to a readjusted size of USD 10910 million by 2030 with a CAGR of 3.2% during review period. This report studies the Neuropathy Pain Treatment market, Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain. Global Neuropath......
  • Global Type 1 Diabetes Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Type 1 Diabetes Therapeutics market: According to our latest research, the global Type 1 Diabetes Therapeutics market looks promising in the next 5 years. As of 2022, the global Type 1 Diabetes Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in w......
  • Global Diabetic Neuropathy Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 104
    Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......
  • Global Diabetic Neuropathy Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are com......
  • Global Diabetic Nephropathy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 23-Nov-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Diabetic Nephropathy market: According to our latest research, the global Diabetic Nephropathy market looks promising in the next 5 years. As of 2022, the global Diabetic Nephropathy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Diabetic nephropathy (DN) is a chronic loss of renal function in diabetic patients. This report covers a research ti......
  • Global Glycated Albumin Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166
    Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......
  • Global Glycated Albumin Professional Survey Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 106
    Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs